Cathodal tDCS in MCI: A Randomized, Double-Blind, Sham-Controlled Pilot Study
CompletedNAResults postedLast updated 25 March 2020
What this trial tests
NA trial testing Soterix Medical 1x1 Low Intensity Transcranial Electrical Stimulator (tES) Model 2001 in Mild Cognitive Impairment in 16 participants. Completed in 31 May 2019.
Timeline
20 February 2018
Primary endpoint 31 May 2019
31 May 2019
Quick facts
Lead sponsor
Mayo Clinic
Phase
NA
Status
Completed
Study type
INTERVENTIONAL
Allocation
randomized
Design
parallel
Masking
double
Primary purpose
treatment
Enrollment
16
Start date
20 February 2018
Primary completion
31 May 2019
Estimated completion
31 May 2019
Sites
1 location across United States
Drugs / interventions tested
Soterix Medical 1x1 Low Intensity Transcranial Electrical Stimulator (tES) Model 2001
Adults 55 to 85, any sex, with Mild Cognitive Impairment or Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Change in Flanker Inhibitory Control and Attention Test ScoresPrimary· Baseline, 1-month post intervention
Post-intervention score comparison between the intervention and control group measured by the NIH Toolbox Cognition Battery Test. The NIH Toolbox Cognition Battery Test is a comprehensive set of neuro behavioral measurements used to assess cognitive, sensory and motor functions where a higher composite score equals better cognitive performance. The NIH Toolbox Cognitive Scores used the Fully Adjusted Scale score (also referred to as the fully corrected T-score) with a mean of 50 and standard deviation of 10.
Group
Value
95% CI
Active tDCS
35.1
± 1.3
Sham tDCS
41.5
± 1.3
Change in Picture Vocabulary Test ScoresPrimary· Baseline, 1 month post intervention
Post-intervention score comparison between the intervention and control group measured by the NIH Toolbox Cognition Battery Test. The NIH Toolbox Cognition Battery Test is a comprehensive set of neuro behavioral measurements used to assess cognitive, sensory and motor functions where a higher composite score equals better cognitive performance. The NIH Toolbox Cognitive Scores used the Fully Adjusted Scale score (also referred to as the fully corrected T-score) with a mean of 50 and standard deviation of 10.
Group
Value
95% CI
Active tDCS
52.0
± 1.2
Sham tDCS
52.0
± 1.2
Change in List Sorting Working Memory Test ScoresPrimary· Baseline, 1 month post intervention
Post-intervention score comparison between the intervention and control group measured by the NIH Toolbox Cognition Battery Test. The NIH Toolbox Cognition Battery Test is a comprehensive set of neuro behavioral measurements used to assess cognitive, sensory and motor functions where a higher composite score equals better cognitive performance. The NIH Toolbox Cognitive Scores used the Fully Adjusted Scale score (also referred to as the fully corrected T-score) with a mean of 50 and standard deviation of 10.
Group
Value
95% CI
Active tDCS
60.5
± 1.9
Sham tDCS
51.8
± 1.9
Change in Dimensional Change Card Sort TestPrimary· Baseline, 1 month post intervention
Post-intervention score comparison between the intervention and control group measured by the NIH Toolbox Cognition Battery Test. The NIH Toolbox Cognition Battery Test is a comprehensive set of neuro behavioral measurements used to assess cognitive, sensory and motor functions where a higher composite score equals better cognitive performance. The NIH Toolbox Cognitive Scores used the Fully Adjusted Scale score (also referred to as the fully corrected T-score) with a mean of 50 and standard deviation of 10.
Group
Value
95% CI
Active tDCS
43.7
± 2.8
Sham tDCS
48.0
± 2.8
Change in Pattern Comparison Processing Speed Test ScoresPrimary· Baseline, 1 month post intervention
Post-intervention score comparison between the intervention and control group measured by the NIH Toolbox Cognition Battery Test. The NIH Toolbox Cognition Battery Test is a comprehensive set of neuro behavioral measurements used to assess cognitive, sensory and motor functions where a higher composite score equals better cognitive performance. The NIH Toolbox Cognitive Scores used the Fully Adjusted Scale score (also referred to as the fully corrected T-score) with a mean of 50 and standard deviation of 10.
Group
Value
95% CI
Active tDCS
46.6
± 3.0
Sham tDCS
51.6
± 3.0
Change in Picture Sequence Memory Test v2.1 ScorePrimary· Baseline, 1 month post intervention
Post-intervention score comparison between the intervention and control group measured by the NIH Toolbox Cognition Battery Test. The NIH Toolbox Cognition Battery Test is a comprehensive set of neuro behavioral measurements used to assess cognitive, sensory and motor functions where a higher composite score equals better cognitive performance. The NIH Toolbox Cognitive Scores used the Fully Adjusted Scale score (also referred to as the fully corrected T-score) with a mean of 50 and standard deviation of 10.
Group
Value
95% CI
Active tDCS
45.2
± 3.8
Sham tDCS
42.8
± 3.8
Change in Oral Reading Recognition Test ScorePrimary· Baseline, 1 month post intervention
Post-intervention score comparison between the intervention and control group measured by the NIH Toolbox Cognition Battery Test. The NIH Toolbox Cognition Battery Test is a comprehensive set of neuro behavioral measurements used to assess cognitive, sensory and motor functions where a higher composite score equals better cognitive performance. The NIH Toolbox Cognitive Scores used the Fully Adjusted Scale score (also referred to as the fully corrected T-score) with a mean of 50 and standard deviation of 10.
Group
Value
95% CI
Active tDCS
58.5
± 1.7
Sham tDCS
56.1
± 1.7
Sponsor's own description
This study evaluates the application of non-invasive brain stimulation in the treatment of Mild Cognitive Impairment (MCI) in adults aged 55-85. Half of the participants will receive transcranial direct current stimulation (tDCS), while the other half will receive sham (like placebo) stimulation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Other recruiting trials for Mild Cognitive Impairment
Currently open trials in the same condition.
NCT05791994 — EVASION: Effect of VisuAl Stimulation on attentION
· NA
· recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
· Phase 1
· recruiting
NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen
· NA
· recruiting
NCT06983769 — CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial
· NA
· recruiting
NCT07318038 — The Use of Rhythmic Light Therapy in Mild Cognitive Impairment
· NA
· recruiting
Other Mayo Clinic trials
Trials by the same sponsor.
NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men
· NA
· not yet recruiting
NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration
· not yet recruiting
NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance,
· NA
· not yet recruiting
NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE)
· NA
· recruiting
NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
Last refreshed: 25 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03521089.